Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLIC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GJA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
P2RX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01049 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC30B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGMA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO7B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FXR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505715 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASAH2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKACB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on